Business Standard

Mid, small-cap pharma stocks rally; Dishman Carbogen, Unichem Labs soar 20%

Panacea Biotec, Nectar Lifesciences, and Vimta Labs, too, were frozen at 20 per cent upper circuit on the BSE.

pharma, medicines, drugs
Premium

Dishman Carbogen Amcis, too, was locked in the upper circuit of 20 per cent at Rs 123.

SI Reporter Mumbai
Shares of mid-and-smallcap pharmaceutical stocks were in focus on Wednesday as the stocks rallied up to 20 per cent on the back of positive corporate announcements.

Panacea Biotec, Dishman Carbogen Amcis, Unichem Laboratories, Nectar Lifesciences, and Vimta Labs were frozen at 20 per cent upper circuit on the BSE. In comparison, the S&P BSE Sensex was up 0.80 per cent at 34,228 points at 12:45 pm.

Granules India, Morepen Laboratories, Amrutanjan Healthcare, Vivimed Labs, Bal Pharma, Ind-Swift Laboratories, Jubilant Life Sciences, and Kopran were up 10 per cent to 17 per cent on the BSE. Biocon, Alembic Pharmaceuticals, Torrent Pharmaceuticals, and Ipca

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in